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Background: SHOX alterations have been reported in 67% of patients affected by Léri-Weill dyschondrosteosis
(LWD), with a larger prevalence of gene deletions than point mutations. It has been recently demonstrated that
these deletions can involve the SHOX enhancer region, rather that the coding region, with variable phenotype of
the affected patients.
Here, we report a SHOX gene analysis carried out by MLPA in 14 LWD patients from 4 families with variable phenotype.
Case presentation: All patients presented a SHOX enhancer deletion. In particular, a patient with a severe bilateral
Madelung deformity without short stature showed a homozygous alteration identical to the recently described 47.5 kb
PAR1 deletion. Moreover, we identified, for the first time, in three related patients with a severe bilateral Madelung
deformity, a smaller deletion than the 47.5 kb PAR1 deletion encompassing the same enhancer region (ECR1/CNE7).
Conclusions: Data reported in this study provide new information about the spectrum of phenotypic alterations
showed by LWD patients with different deletions of the SHOX enhancer region.
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SHOX deficiency represents a frequent cause of short
stature, being associated with different pathological phe-
notypes such as Turner syndrome (TS), Idiopathic Short
Stature (ISS; MIM ID 300582), Léri-Weill dyschondros-
teosis (LWD; MIM ID 127300) and Langer mesomelic
dysplasia (LS; MIM ID 249700) [1-10].
LWD is characterized by the presence of short stature
associated with specific bone alterations, such as the
Madelung deformity of the forearm. However, the full-
blown LWD phenotype is frequently not determined in
pre-schooler children because the specific features of this
condition (i.e. mesomelic disproportion of the limbs and
Madelung deformity), appears during the second decade of
life [11-13]. As a consequence, in many cases short stature
represents the only clinical sign at diagnosis. All together,* Correspondence: v.gatta@unich.it
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unless otherwise stated.mutations affecting the SHOX function in the different
pathological conditions display an estimate frequency of
less than 1:1000, thus representing the most common
mendelian disease in the Caucasian population [14].
Due to this high frequency of alterations of the SHOX
gene and to the recently demonstrated good response to
the treatment with growth hormone (GH) in patients
with SHOX deficiency, the early identification of SHOX
alterations has become crucial for the diagnosis of the
disease and the therapeutic strategy [15]. In this view, a
phenotype scoring system assisting the identification of
the most appropriate subjects for SHOX testing has been
developed by Rappold et al. [16], recommending SHOX
analysis in presence of a score greater than four out of a
total possible score of 24. Moreover, Binder described an
interesting algorithm approach to SHOX mutation screen-
ing in short children, promoting the clinical diagnosis sup-
ported by an auxological analysis of the body proportions
(mesomelia), the presence of minor abnormalities, and the
search for subtle radiographic signs and the molecular
studies for confirming clinical data [17].
A large number of literature reports have demon-
strated the presence of SHOX alterations in about 67%td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Pedigree of the four families. Black icon: clinically
affected; white symbol: clinically unaffected; Δ: deletion; +: no mutation;
?: not tested.
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ations are not detected in the vast majority of cases with
idiopathic short stature (85–98%) [9,17,20].
The use of the MLPA assay [18-21] has disclosed that
deletions can involve not only the SHOX coding region,
but also the upstream and downstream SHOX enhancer
sequences [22-25].
Recently, Benito-Sanz et al. [26] provided a deep
characterization of a relatively small deletion of PAR1,
previously reported by Chen et al. [10] and Caliebe et al.
[27], uncovering a novel downstream enhancer. This de-
letion is correlated with a remarkably variable phenotype
of patients [28], confirming the evidence that deletion
size is not related with the severity of the clinical pheno-
type [29], which, despite the high penetrance of SHOX
deficiency, is very variable becoming more pronounced
with age and being more severe in females [17].
The identification of PAR1 deletions not involving the
SHOX coding regions have raised novel interest to the
knowledge of the mechanisms leading to short stature in
cases with SHOX deficiency.
In order to provide a contribute to this field of studies,
we report on SHOX gene analysis in LWD patients with
selected dysmorphic signs derived from four families, all
evidencing deletions of the enhancer region, which was
present in homozygous form in a patient with Madelung
deformity but normal stature.
Case presentation
A written informed consent was obtained from each
patient. The different techniques were performed ac-
cording to standard procedures of the participating
centers, with the purpose to reach a genetic diagnosis in
the studied patient. It was not designed as an experi-
mental study.
Family 1
The index case (Figure 1-n.1) was a 12-years and
10 months girl admitted to the outpatient Endocrine
Clinic of the Department of Pediatrics, University of
Chieti, Italy, for short stature. The girl was the first
offspring of unrelated healthy parents. She has one 10-
year-old sister, who had a normal linear and ponderal
growth. The girl was born after 39 weeks of gestation
after an unremarkable pregnancy. Birth anthropometric
measurements were the following: weight 2.500 kg (3th-
10th percentile), length 48 cm (10th-25th percentile).
From the first months of life she had slow linear and
ponderal growth, with normal psychomotor develop-
ment. At our first clinical evaluation she showed short
stature (140.6 cm, −2.18 SDS). Sitting height was 75 cm
(−2.0 SDS), sitting height/height ratio was 0.53 (+1.0
SDS) and arm span/height ratio was 96.7%. BMI was be-
tween 25th-50th percentile and head circumference wasnormal. She had mesomelia with muscular hypertrophy.
No facial dysmorphism was detected except for mild
webbed neck. Radiological examination of the forearms
showed bilaterally slight triangular deformation of distal
radial epiphysis and mild bowing of radial diaphysis; legs
were normal. Bone age according to Greulich and Pyle
was 13.8 yr. Based on the detected clinical and radio-
logical signs, the total Rappold’s score was 6 (Table 1).
The 49-year-old mother of the proband (Figure 1-n.2)
also showed short stature (149 cm, −2.0 SDS). Sitting
height was 72 cm (< −2.0 SDS), sitting height/height ra-
tio was 0.48 cm (< −2.5 SDS) and arm span/height ratio
was 93%. BMI was >50th percentile. She had mesomelia
with muscular hypertrophy. No facial dysmorphisms
were detected except for mild webbed neck. Radio-
logical examination of the radius and ulna showed
bilateral Madelung deformity; legs were normal. The
total Rappold’s score was 12 (Table 1).
Family 2
The index case (Figure 1-n.3) was a 3-years and 11 months
girl admitted to the outpatient Endocrine Clinic of the
Department of Pediatrics, University of Chieti, Italy, for
short stature. The girl was the second offspring of unre-
lated healthy parents. She has one 6-year-old healthy
sister, showing normal linear and ponderal growth. The
girl was born after 38 weeks of gestation after an un-
remarkable pregnancy. Birth anthropometric measure-
ments were the following: weight 2.820 kg (10th-25th
percentile), length 48.5 cm (25th-50th percentile). From
the first months of life she had slow linear growth,
whereas ponderal growth and psychomotor develop-
ment were normal. At our first clinical evaluation she
showed short stature (91.3 cm, −2.53 SDS). Sitting
height was 72.6 cm (<−2.5 SDS), sitting height/height
Table 1 Clinical characteristics of 14 patients with a deletion in the downstream enhancer region of SHOX




















n.1 12y10m (F) heterozygous del 13296-L15336,
05645-L05099 and 05646-L15507
96.7% (0) 53% (0) <50°c (0) Absent (0) Present (3) Absent (0) Present (3) Absent (0) 6
n.2 49y (F) heterozygous del 13296-L15336,
05645-L05099 and 05646-L15507
93% (2) 48% (0) > 50°c (4) Absent (0) Present (3) Absent (0) Present (3) Absent (0) 12
FAMILY 2
n.3 3y11m (F) heterozygous del 13296-L15336,
05645-L05099 and 05646-L15507
100% (0) 53% (0) >50°c (4) Present (2) Present (3) Absent (0) Present (3) Absent (0) 12
n.4 39y (F) heterozygous del 13296-L15336,
05645-L05099 and 05646-L15507
98% (0) 41.9% (0) >50°c (4) Present (2) Present (3) Absent (0) Present (3) Absent (0) 12
n.5 10y (F) heterozygous del 13296-L15336,
05645-L05099 and 05646-L15507
100% (0) 47.8% (0) >50°c (4) Present (2) Present (3) Absent (0) Present (3) Absent (0) 12
n.6 46y (F) heterozygous del 13296-L15336,
05645-L05099 and 05646-L15507
98% (0) 47.2% (0) <50°c (0) Present (2) Present (3) Absent (0) Present (3) Absent (0) 8
n.7 48y (F) heterozygous del 13296-L15336,
05645-L05099 and 05646-L15507
96% (2) 49% (0) >50°c (4) Absent (0) Present (3) Absent (0) Present (3) Absent (0) 12
FAMILY 3
n.8 30y (F) homozygous del 13296-L15336,
05645-L05099 and 05646-L15507
98% (0) 54% (0) <50°c (0) Present (2) Present (3) Present (3) Present (3) Present (5) 16
n.9 2y10m (F) heterozygous del 13296-L15336,
05645-L05099 and 05646-L15507
94% (2) 56.9% (2) <50°c (0) Absent (0) Present (3) Absent (0) Absent (0) Absent (0) 7
n.10 11 m (F) heterozygous del 13296-L15336,
05645-L05099 and 05646-L15507
94% (2) 58.3% (2) <50°c (0) Absent (0) Present (3) Absent (0) Absent (0) Absent (0) 7
n.11 54y (F) heterozygous del 13296-L15336,
05645-L05099 and 05646-L15507
100% (0) 52% (0) <50°c (0) Present (2) Present (3) Absent (0) Present (3) Absent (0) 8
FAMILY 4
n.12 14,7y (F) heterozygous del 05645-L05099 97% (0) 50% (0) >50°c (4)° Present (2) Absent (0) Absent (0) Present (3) Absent (0) 9
n.13 11y (F) heterozygous del 05645-L05099 97% (0) 48% (0) >50°c (4) Present (2) Absent (0) Absent (0) Present (3) Absent (0) 9
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was 100%. BMI was >95th percentile. The habitus was
muscular, and she had mesomelia and facial dysmor-
phisms, such as mild hypertelorism, left epicanthus,
high-arched palate, mild webbed neck, cubitus and genu
valgus and lordosis. At radiological examination left radius
showed a mild bowing of diaphysis, triangularization of
distal epiphysis and bowing of diaphysis of radius, radio-
lucency of distal radio-ulnar articulation with normality of
left radius, ulnas and wrists (Figure 2E); legs were normal.
Bone age according to Greulich and Pyle was 3 yr. The
total Rappold’s score was 12 (Table 1).Figure 2 Female 39-year-old: Bilateral forearm radiographs show trian
bilaterally; distal radio-ulnar articulations appeared radiographically l
Left forearm radiography shows triangularization of distal epiphysis and bowi
(E). Madelung deformity of family 3 index case (n.8) (F). The lower panel showe
a ratio of 0.65-1.35 (H) Heterozygous deletion of the 13296-L15336, 05645-L050
deletion of the 13296-L15336, 05645-L05099 and 05646-L15507 MLPA probes
MLPA probes.Her mother (Figure 1-n.4) (39-year-old) also showed
short stature (146.4 cm, −2.43SDS). Sitting height was
61.4 cm (<−2.5 SDS), sitting height/height ratio was
41.9%and arm span/height ratio was 98%. BMI was
between 50th-75thpercentile. Muscular hypertrophy was
detected. She had mesomelia with facial dysmorphisms
including mild high-arched palate and webbed neck.
Mild scoliosis with cubitus and genu valgus were de-
tected. The patient suffered from adolescence of diffuse
muscular pain, which at adult age was imputed to fibro-
myalgia. Radiological examination showed triangulariza-
tion of distal epiphysis and bowing of diaphysis of radiusgularization of distal epiphysis and bowing of diaphysis of radius
ucent. Palmar subluxation of the left carpus (A-D). Female 6-year-old:
ng of diaphysis of radius, radiolucency of distal radio-ulnar articulation
s MLPA assay results. (G) Control: Normal peaks were classified as showing
99 and 05646-L15507. MLPA probes have a ratio < 0.65. (I) Homozygous
showing a ratio = 0. (L) Heterozygous deletion of the 05645-L05099
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graphically lucent and legs did not show skeletal anomalies
(Figure 2A-D). The total Rappold’s score was 12 (Table 1).
A 10-year-old cousin (Figure 1-n.5) of the index case
was also admitted for short stature. The girl was the sec-
ond offspring of unrelated healthy parents. She has one
18-year-old healthy brother and one 7-year-old healthy
sister, both of them with normal linear and ponderal
growth. The girl was born after 32 weeks of gestation
after an unremarkable pregnancy. Birth anthropometric
measurements were the following: weight 2.850 kg
(>97th percentile), length 45.2 cm (90th-97th percentile).
From the first months of life she had slow linear growth
with normal ponderal growth. Psychomotor develop-
ment was normal. At our first clinical evaluation she
showed short stature (125.3 cm, −2.07 SDS). Sitting
height was 60 cm (<−2.5 SDS), sitting height/height ratio
was 47.8%, arm span /height ratio was 100%. BMI was
between 85th-90th percentile. The habitus was slightly
muscular, and she had mesomelia and facial dysmor-
phisms, including mild high-arched palate and mild
webbed neck. She also had cubitus valgus and valgus knee.
Bone age according to Greulich and Pyle was 8.6 yr.
Radiological examination of the radius, ulnas and legs did
not show significant bone alterations.The total Rappold’s
score was 12 (Table 1).
Her mother (Figure 1-n.6) (46-year-old), the sister of
index case’s mother, also showed mild linear impair-
ment (149.8 cm, −1.86 SDS). Sitting height was 70.8 cm
(<−2.5 SDS), sitting height/height ratio was 47.2 (<−2.5
SDS) and arm span /height ratio was 98%. BMI was be-
tween 25th-50th percentile. The habitus was muscular, and
she had mesomelia, cubitus valgus without facial dys-
morphisms. The patient suffered from adolescence of dif-
fuse muscular pain, which at adult age was imputed to
fibromyalgia. Radiological examination showed bilaterally
triangularization of distal epiphysis and bowing of diaphysis
of radius, radiolucency of distal radio-ulnar articulation;
legs were normal.The total Rappold’s score was 8 (Table 1).
Another sister of index case’s mother (Figure 1-n.7)
(48-year-age old) also showed mild linear impairment
(150.4 cm, −1.76 SDS). Sitting height was 75 cm (<−2.5
SDS), sitting height/height ratio was 49 (<−2.25 SDS)
and arm span /height ratio was 96%. BMI was between
85th-95th percentile. The habitus was muscular, and she
had mesomelia. The patient suffered from adolescence
of diffuse muscular pain, which at adult age was imputed
to fibromyalgia. Radiological examination of the radius
and ulna showed bilateral Madelung deformity. The total
Rappold’s score was 12 (Table 1).
Family 3
The index case (Figure 1-n.8) was a 30-year-old women
admitted to the outpatient Genetic Clinic, University ofChieti, Italy, for Madelung deformity surgically corrected
at the age of 18 (Figure 2F). The women was the second
offspring of unrelated healthy parents. She has one 26-
year-old healthy brother, who had a normal linear and
ponderal growth. The women was born at term after an
unremarkable pregnancy. Birth anthropometric mea-
surements were in the normal rage. From the first
months of life she had slow linear growth with normal
ponderal growth and psychomotor development. At our
first clinical evaluation she did not show short stature
(155.6 cm, −0.89 SDS). Sitting height was 84 cm (< −2.5
SDS), sitting height/height ratio was 54% (< −2.5 SDS)
and arm span/height ratio was 98%. BMI was between
25th-50th percentile. The habitus was muscular, and she
had mesomelic, facial dysmorphisms (hypertelorism) and
cubitus and genu valgus with scoliosis. The patient suffered
from adolescence of diffuse muscular pain. Radiological
examination of the radius and ulna showed bilateral Made-
lung deformity (Figure 2F). The total Rappold’s score was
16 (Table 1).
This patient had two daughters. The first girl (Figure 1-
n.9) was born after 37 weeks of gestation after an unre-
markable pregnancy. Birth anthropometric measurements
were the following: weight 2.560 kg (10th-25thpercentile),
length 49.5 cm (75th-90th percentile). She showed decrease
of linear growth from the age of 21 months, while poor
ponderal growth was detected from the age of 1 year. Psy-
chomotor development was normal. At our first clinical
evaluation she was 2-years and 10 months old. She
showed short stature (87 cm, −2.09 SDS). Sitting height
was 49 cm (<−2.5 SDS), sitting height/height ratio was
56.9% (<−2.0 SDS) and arm span/height ratio was 94%.
BMI was at 10th percentile. Head circumference was nor-
mal. The habitus was not muscular, and she had mesome-
lia and facial dysmorphisms, including hypertelorism,
epicanthus and mild webbed neck. Bone age according to
Greulich and Pyle was 2.5 yr. Radiological examination of
the forearms was normal.The total Rappold’s score was 7
(Table 1).
The second girl (Figure 1-n.10) was born after 37 weeks
of gestation after an unremarkable pregnancy. Birth
anthropometric measurements were the following: weight
2.430 kg (3th-10th percentile), length 46 cm (10th-25th per-
centile). She showed poor linear and ponderal growth
from the age of six months. Psychomotor development
was normal.At our first clinical evaluation she was 11-
month-old. She showed short stature (72 cm, −4.11 SDS).
Sitting height was 42 cm (< −2.5 SDS), sitting height/
height ratio was 58.3% (<−2.5 SDS) and arm span/height
ratio was 94%. BMI was at 10th percentile. Head circum-
ference was normal.The habitus was not muscular. She
did not show mesomelia but facial dysmorphisms were
detected, including epicanthus, hypertelorism and mild
webbed neck. Bone age according to Greulich and Pyle
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was normal.The total Rappold’s score was 7 (Table 1).
The index case’s mother (Figure 1-n.11) (54 year-old)
did not show short stature (159 cm, −0.32 SDS). Sitting
height was 75 cm (<−2.5 cm), sitting height/height ratio
was 52% (<−2.5 SDS) and arm span/height ratio was
100%. BMI was between 25th-50th percentile. The hab-
itus was muscular, and she had mesomelia with facial
dysmorphisms (hypertelorism) and mild scoliosis. Radio-
logical examination of the radius and ulna showed bilateral
Madelung deformity, with left ulnar dorsal dislocation. The
total Rappold’s score was 8 (Table 1).
Family 4
The index case (Figure 1-n.12) was a 14-years and
7 months girl admitted to the outpatient Endocrine
Clinic of the Department of Pediatrics, University of
Chieti, Italy, for short stature. The girl was the first off-
spring of unrelated healthy parents. She was born after
40 weeks of gestation after an unremarkable pregnancy.
Birth anthropometric measurements were the following:
weight 3.180 kg (25th-50th percentile), length 48 cm
(10th-25th percentile). From the first months of life she
had slow linear and ponderal growth, with normal psy-
chomotor development. At our first clinical evaluation
she showed short stature (147.6 cm, −1.79 SDS). Sitting
height was 75 cm (−2.5 SDS), sitting height/height ratio
was 0.50 (−2.0 SDS) and arm span/height ratio was 97%.
BMI was between 50th-75th percentile and head circum-
ference was normal. She had mild webbed neck, muscu-
lar hypertrophy, pectus carenatum, and cubitus and
genu valgus. Radiological examination of the radius and
ulna showed bilateral Madelung deformity. Bone age ac-
cording to Greulich and Pyle was 16 yr. Based on the de-
tected clinical and radiological signs, the total Rappold’s
score was 9 (Table 1).
The sister of the proband (Figure 1-n.13) (11-year-old)
showed a normal linear growth (138 cm, −1.0 SDS), sit-
ting height was 67 cm (< −2.5 SDS), sitting height/height
ratio was 0.48 cm (< −2.5 SDS) and arm span/height ra-
tio was 97%. BMI was >85th percentile. She had muscu-
lar hypertrophy, pectus carenatum, and cubitus and
genu valgus. Radiological examination showed bilaterally
triangularization of distal epiphysis and bowing of dia-
physis of radius, correlated to Madelung deformity. Bone
age according to Greulich and Pyle was 12 yr. The total
Rappold’s score was 9 (Table 1).
The mother of the proband (Figure 1-n.14) (42-year-
old) also showed normal stature (160.2 cm, −0.12 SDS).
Sitting height was 80 cm (< −2.5 SDS), sitting height/
height ratio was 0.50 cm (< −2.0 SDS) and arm span/
height ratio was 93%. BMI was >95th percentile. She had
mild mesomelia with muscular hypertrophy. No facial
dysmorphisms were detected except for webbed neck.The patient suffered from adolescence of diffuse mus-
cular pain.Radiological examination of the radius and
ulna showed bilateral Madelung deformity. The total
Rappold’s score was 12 (Table 1).
Laboratory investigations allowed us to exclude thy-
roid dysfunction, abnormal IGF-1 levels and celiac dis-
ease in all the investigated patients, which all had
normal diploid karyotype.
Molecular analysis
Genomic DNA was extracted from peripheral blood or
buccal swab by QIAamp DNA Blood Midi Kit (Qiagen,
Hilden, Germany). SHOX deletions were detected using
the MRC-Holland MLPA kit (Salsa P018-E and F1;
MRC-Holland, Netherlands – Resnova, Italy) according
to the manufacturer’s instructions. The P018-D1 SHOX
probemix contains 44 MLPA probes with amplification
products between 130 and 463 nt. Seven of these probes
are specific for each exon of the human SHOX gene and
one is mapped just before the SHOX promoter region
(4 kb before SHOX-PAR1). In addition, 14 probes are
present detecting sequences in a region downstream of
SHOX which has been implicated in regulation of SHOX
transcription. Furthermore, nine probes on the X
chromosome, out of PAR regions, are included in this
probemix. Finally, ten autosomal reference probes are
included. All the patients were also investigated with the
last MLPA SHOX probemix (P018-F1) that as compared
to oldest D1version three new probes near the PAR1
boundary have been included. Two probes (GPR143 and
13296-L15336) has been removed. The 88 and 96 nt
control fragments have been replaced (QDX2) (http://
www.mrc-holland.com). Data Analysis was performed
using the Coffalyser software v. 9.4 (http://coffalyser.
wordpress.com/).
In order to rule out false positive cases due to the
presence of polymorphisms hampering the MLPA probe,
we further investigated cases with deletion using PCR
amplification with primers mapped within the probes re-
gion (SHOX_318 F: ACACCCAGTCATGAATGCAA;
SHOX_318 R: CTTGGCTGGACAGACTCAGG; SHOX_
432 F: ACATCGGCCTTTCCAAATAA; SHOX_432R:
CTCGGGAGGCAGAGAGATTT), followed by direct
sequencing on ABI 3130XL (ABI, Warrington, UK).
Results
MLPA analysis, carried out in the four index patients
and their familiars (N = 10), evidenced a heterozygous
deletion of probes 13296-L15336, 05645-L05099 and
05646-L15507 (47543 bp deletion) in nine patients
(patients 1–7, 9, 10) and a homozygous deletion of the
same probes in the patient n. 8 (Figure 2H, I). A heterozy-
gous deletion encompassing only the probe 05645-L05099
was revealed in three related patients (patients 12–14)
Gatta et al. BMC Medical Genetics 2014, 15:87 Page 7 of 9
http://www.biomedcentral.com/1471-2350/15/87(Figure 2L). All detected deletions involved a distinct SHOX
enhancer region, not affecting the SHOX coding region.
All the data were confirmed using the latest MLPA
SHOX probemix (P018-F1). Since in this last probe mix
version the probe 13296-L15336 was removed because
not reliable, the 47543pb deletion was characterized by
the absence of the remaining two MLPA probes 05645-
L05099 and 05646-L15507.
MLPA results were confirmed by PCR and DNA se-
quencing, showing absence of amplification in the patient
with a homozygote deletion and absence of polymor-
phisms in all the observed heterozygous deletions.
Discussion
The SHOX gene belongs to a family of transcriptional
regulators that are mainly expressed in the middle portion
of the limbs where assure the correct balance between
proliferation and apoptosis during bone development. The
absence of wild type SHOX would promote atypical proli-
feration of the chondrocytes combined with defective
differentiation, leading to retarded longitudinal bone
growth [30,31]. This specific pattern of expression can
explain the wide phenotypic variability of SHOX defi-
ciency patients with cases of normal stature but mesome-
lia and Madelung deformity.
In the present study we investigated SHOX region
molecular defect in four LWD families, three of which
showed the recurrent ~47.5 kb PAR1 deletion, previ-
ously described by Benito-Sanz et. al [26]. This deletion
is mapped downstream of the SHOX gene and contains
an enhancer sequence (ECR1/CNE7). The deletion was
present in heterozygous state in all the analyzed mem-
bers except one case of homozygous deletion, which sur-
prisingly presented severe bilateral Madelung deformity
but a normal stature within her target height range.
The fourth analyzed family is of particular interest,
since we found, for the first time, a heterozygous dele-
tion encompassing only one of the three classical MLPA
probes characterizing the recurrent – 47.5 kb PAR1 de-
letions. The rearrangement cosegregated with the LWD
phenotype in all the members of the family, with a cli-
nical phenotype similar to the one showed by cases with
larger deletion, confirming a pathogenic effect also of
this shorter enhancer deletion. Looking in detail at this
group of 14 patients it appears evident that the pheno-
type of patients with deletions in the 3’-PAR1 region is
remarkably variable and not related to the extension or
the homozygous and heterozygous form. Up to date only
a few studies have been performed concerning the
phenotype showed by patients carrier of enhancer dele-
tions, all suggesting a great variability [7,28]. Kant et al.
described a case in which the enhancer deletion was
associated with normal stature, although below the tar-
get height range [28].In order to better assess the clinical expression in our
cohort, we calculated the Rappold score of the investi-
gated patients [16]. Interestingly, all patients had a score
greater than 4 with a median value of 11.5 (range 6–13),
but a great variability was found among the different
clinical signs. In fact, short forearm and muscular hyper-
trophy were the two most observed dysmorphic abnor-
malities (100% and 80%, respectively), while cubitus
valgus and BMI greater than 50th percentile were less
frequent (60% and 40%, respectively). Unexpectedly, arm
span/height ratio and sitting height/height ratio were
uncommon (30% and 20%, respectively), whereas bowing
of forearm and tibia as well as dislocation of ulna at the
elbow were present only in one subject (Table 1).
The results obtained from the study of these four fam-
ilies suggest that, even if all the patients were eligible for
the SHOX molecular analysis, some of the Rappold cri-
teria are not very distinctive for SHOX deficiency. In
fact, we had to take into account other characteristics,
such as Madelung deformity, found in 60% of our sam-
ple. Therefore, it could be speculated that mutations in
the SHOX enhancer region seem to be responsible
mainly for bone deformities. In fact, both the homozy-
gous case and her mother, who presented a heterozygous
mutations in the SHOX enhancer region, showed bila-
teral Madelung deformity but not short stature.
The explanation of these findings probably is corre-
lated with the etiology of the Madelung deformity, which
originates with disorganized growth of part of the radial
epiphysis, leading to radial bowing, premature fusion of
that epiphysis, dorsal dislocation of the ulna, and wedged
carpal bones. The premature fusion of the physis leads to
cessation of longitudinal growth, and is always located in
the ulnar zone of the distal radius but varies in the antero-
posterior plane [32].
According to literature data, in our cohort, we did not
find a correlation between bone defect, gender and the
deletion size. These could be related to estrogens influ-
ence on the growth plate, which worse dyschondrosteo-
sis leading to severe bone pain [33]. In this respect, it is
interesting to underline that in this report many patients
suffered from chronic widespread pain and received
diagnosis of fibromyalgia. Since the pathogenesis of this
musculoskeletal disorder is still unknown, a potential
role of SHOX gene could be hypothesized, and further
studies are required to clarify the relationship between
SHOX deficit and fibromyalgia. In addition there isn’t an
age-dependent phenotype in these subjects.
Conclusions
In conclusion, the present report confirms the usefulness
to perform SHOX analysis including the enhancer
sequence in patients with elevated Rappold’s score. In
addition, it could be useful to follow-up these patients in
Gatta et al. BMC Medical Genetics 2014, 15:87 Page 8 of 9
http://www.biomedcentral.com/1471-2350/15/87order to verify the onset of fibromyalgia or other chronic
idiopathic musculoskeletal disorders. Finally, the detec-
tion of a case of homozygous deletion of this region in a
patient with severe bilateral Madelung deformity but a
normal stature suggests the role of SHOX gene enhancer
in contributing to different anomalies, which constitutes
a wide spectrum of the disease. Therefore, the SHOX de-
ficiency represents a complex and heterogeneous group
of conditions ranging from the more severe phenotype
(Langer syndrome) to milder forms (isolated short
stature/isolated Madelung deformity).
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